"Ralph Snyderman, M.D. served as Chancellor for Health Affairs and Dean of the School of Medicine at Duke University from 1989 to July 2004 and led the transition of this excellent medical center into an internationally recognized leader of academic medicine. He oversaw the development of the Duke University Health System, one of the most successful integrated academic health systems in the country, and served as its first president and chief executive officer...
"Dr. Snyderman has been widely recognized for his contributions to the development of more rational, effective, and compassionate models of health care. He was awarded the first Bravewell Leadership Award for outstanding achievements in the field of integrative medicine in 2003. In 2007, he received the Leadership in Personalized Medicine Award from the Personalized Medicine Coalition for his efforts in advancing predictive and targeted therapies on a national scale. In 2008, Dr. Snyderman received Frost & Sullivan’s North American HealthCare Lifetime Achievement Award for his pioneering spirit and contributions to medicine. In 2009, he received the Triangle Business Journal’s Healthcare Lifetime Achievement Award. In 2010, Procter & Gamble named Snyderman an honorary member of the Victor Mills Society for his leadership and impact on innovation and he was recognized as a Bioscience Leader Emeriti by the NC Association for Biomedical Research honoring North Carolina research leaders for their outstanding leadership in the transformation of the state through scientific discovery and innovation..."
"Dr. Ralph D. Snyderman, M.D. co-founded Proventys, Inc. in 2004 He is James B. Duke Professor of Medicine in Duke University School of Medicine. He served as Venture Partner of New Enterprise Associates (NEA) since January 23, 2006. Dr. Snyderman has an extensive knowledge of the healthcare industry...He served as Vice President of Medical Research and Development at Genta Incorporated... Dr. Snyderman served as the Senior Vice President of Medical Research and Development at Genentech Inc. from January 1987 to May 1989... Dr. Snyderman has been a Director of Pharmaceutical Product Development, LLC (also known as Pharmaceutical Product Development Inc.) since May 18, 2011 and XDx, Inc. since April 2005. He serves as a Director of Crescendo Bioscience, Inc., RealMed Corporation, and Liquidia Technologies, Inc. He serves as a Director of National Health Museum. He has been a Director of Press Ganey Associates, Inc. since February 27, 2013. He serves as Member of the Clinical Advisory Board and Member of the Scientific Advisory Board for Cardioxyl Pharmaceuticals, Inc. He serves on the Washington College Board of Visitors and Governors. Dr. Snyderman served as a Member of Advisory Board of Burrill Life Sciences Capital Fund II, L.P. He served as a Director of Targacept, Inc. since June 14, 2007 until May 31, 2013. He served as a Director of Somatogen Inc. since March 1989 and Lifemasters Supported Selfcare Inc. since March 2005. He served as a Director of Baxter Hemoglobin Therapeutics, Inc. since March 1989 and SAIC, Inc. since 2002. He served as a Director of Ariad Pharmaceuticals Inc. He served as an Independent Director of Cardiome Pharma Corp., since March 11, 2002. He served as a Director of Trevena, Inc. He served as a Director of Procter & Gamble Co., from 1995 to April 18, 2010. He served as a Director of Axonyx Inc. since March 8, 2004. He was a Counselor of the Institute of Medicine. Dr. Snyderman was President of the Association of American Physicians since 2004. He played a leadership role in the Association of American Physicians, the Institute of Medicine and the Association of American Medical Colleges ("AAMC"). He was Chairman of AAMC from 2001 to 2002." 
- Advisory Board, Bravewell Collaborative
- Former Director, Science Applications International Corporation